| Agalsidase beta |
EU/1/01/188/001 |
Fabrazyme, Powder for concentrate for solution for infusion, 35, mg, Pack: 1 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd., United Kingdom |
5861.64 |
1172.33 |
7033.97 |
4% |
10.00 |
5871.64 |
1174.33 |
7045.97 |
16% |
25.00 |
5896.64 |
1179.33 |
7075.97 |
|
КЦРР-756/07.06.2012 |
31.07.2012 |
31.07.2012 |
Неактивен |
3215 |
| Agalsidase beta |
EU/1/01/188/001 |
Fabrazyme, Powder for concentrate for solution for infusion, 35, mg, Pack: 1 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd., United Kingdom |
6354.61 |
1270.92 |
7625.53 |
6% |
15.00 |
6369.61 |
1273.92 |
7643.53 |
18% |
30.00 |
6399.61 |
1279.92 |
7679.53 |
|
КЦ-599/23.02.2009 |
12.03.2009 |
12.03.2009 |
Неактивен |
3215 |
| Famotidine |
15637/29.12.2006 г. |
FAMOTIDINE ALKALOID, Film coated tablet, 20, mg, Pack: 20 |
Алкалоид ЕООД, България |
Alkaloid-INT d.o.o. Slovenia |
0.82 |
0.16 |
0.98 |
7% |
0.06 |
0.88 |
0.18 |
1.06 |
20% |
0.16 |
1.04 |
0.21 |
1.25 |
промяна на обстоятелства решение КЦPP-2321/20.02.2013; цената е заличена с решение НСР-4837/17.10.2014 (в сила от 16.11.2014 ) |
КЦ-221/19.09.2008 |
21.10.2008 |
21.10.2008 |
Заличен |
113 |
| Famotidine |
9800117 |
Famultran, Film coated tablet, 40, mg, Pack: 30 |
Актавис EАД, България |
Балканфарма- Дупница АД |
2.80 |
0.56 |
3.36 |
7% |
0.20 |
3.00 |
0.60 |
3.60 |
20% |
0.56 |
3.56 |
0.71 |
4.27 |
промяна на обстоятелства НСР-10863/ 10.11.2016 |
КЦ-222/19.09.2008; НСР-11456/13.01.2017 |
21.10.2008 |
02.02.2017 |
Заличен |
89 |
| Famotidine |
9800117 |
Famultran, Film coated tablet, 40, mg, Pack: 30 |
Актавис EАД, България |
Балканфарма- Дупница АД |
2.80 |
0.56 |
3.36 |
7% |
0.20 |
3.00 |
0.60 |
3.60 |
20% |
0.56 |
3.56 |
0.71 |
4.27 |
промяна на обстоятелства НСР-10863/ 10.11.2016 |
КЦ-222/19.09.2008 |
21.10.2008 |
02.12.2016 |
Неактивен |
89 |
| Famotidine |
9800116 |
Famultran, Film coated tablet, 20, mg, Pack: 30 |
Актавис EАД, България |
Балканфарма- Дупница АД |
1.50 |
0.30 |
1.80 |
7% |
0.10 |
1.60 |
0.32 |
1.92 |
20% |
0.30 |
1.90 |
0.38 |
2.28 |
промяна на обстоятелства НСР-10864/ 10.11.2016 |
КЦ-222/19.09.2008; НСР-11455/13.01.2017 |
21.10.2008 |
02.02.2017 |
Заличен |
88 |
| Famotidine |
9800116 |
Famultran, Film coated tablet, 20, mg, Pack: 30 |
Актавис EАД, България |
Балканфарма- Дупница АД |
1.50 |
0.30 |
1.80 |
7% |
0.10 |
1.60 |
0.32 |
1.92 |
20% |
0.30 |
1.90 |
0.38 |
2.28 |
промяна на обстоятелства НСР-10864/ 10.11.2016 |
КЦ-222/19.09.2008 |
21.10.2008 |
02.12.2016 |
Неактивен |
88 |
| Famotidine |
16195/06.04.2007 |
Famultran, Film coated tablet, 20, mg, Pack: 30 |
Актавис EАД, България |
Балканфарма- Дупница АД |
1.50 |
0.30 |
1.80 |
7% |
0.11 |
1.61 |
0.32 |
1.93 |
20% |
0.30 |
1.91 |
0.38 |
2.29 |
|
КЦ-222/19.09.2008 |
21.10.2008 |
21.10.2008 |
Неактивен |
88 |
| Famotidine |
16196/06.04.2007 |
Famultran, Film coated tablet, 40, mg, Pack: 30 |
Актавис EАД, България |
Балканфарма- Дупница АД |
2.80 |
0.56 |
3.36 |
7% |
0.20 |
3.00 |
0.60 |
3.60 |
20% |
0.56 |
3.56 |
0.71 |
4.27 |
|
КЦ-222/19.09.2008 |
21.10.2008 |
21.10.2008 |
Неактивен |
89 |
| Human coagulation factor VIII |
9900224 |
Fanhdi, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Instituto Grifols, S.A., Испания |
INSTITUTO GRIFOLS S.A.,Spain |
314.42 |
62.88 |
377.30 |
4% |
10.00 |
324.42 |
64.88 |
389.30 |
16% |
25.00 |
349.42 |
69.88 |
419.30 |
Промяна на обстоятелства НСР-13618/25.08.2017 |
КЦ-1449/09.03.2010; протокол №16/04.07.2013.; НСР-15745/25.05.2018 |
09.06.2018 |
02.07.2018 |
Активен |
903 |
| Human coagulation factor VIII |
9900224 |
Fanhdi, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Instituto Grifols, S.A., Испания |
INSTITUTO GRIFOLS S.A.,Spain |
324.43 |
64.89 |
389.32 |
4% |
10.00 |
334.43 |
66.89 |
401.32 |
16% |
25.00 |
359.43 |
71.89 |
431.32 |
Промяна на обстоятелства НСР-13618/25.08.2017 |
КЦ-1449/09.03.2010; протокол №16/04.07.2013. |
26.03.2010 |
02.10.2017 |
Неактивен |
903 |
| Human coagulation factor VIII |
9900225 |
Fanhdi, Powder and solvent for solution for injection, 250, IU, Pack: 1 |
Instituto Grifols, S.A., Испания |
INSTITUTO GRIFOLS S.A.,Spain |
158.56 |
31.71 |
190.27 |
4% |
6.34 |
164.90 |
32.98 |
197.88 |
16% |
25.00 |
189.90 |
37.98 |
227.88 |
Промяна на обстоятелства НСР-13617/25.08.2017 |
КЦ-1449/09.03.2010; протокол №16/04.07.2013.; НСР-15747/25.05.2018 |
09.06.2018 |
02.07.2018 |
Активен |
902 |
| Human coagulation factor VIII |
9900225 |
Fanhdi, Powder and solvent for solution for injection, 250, IU, Pack: 1 |
Instituto Grifols, S.A., Испания |
INSTITUTO GRIFOLS S.A.,Spain |
161.16 |
32.23 |
193.39 |
4% |
6.45 |
167.61 |
33.52 |
201.13 |
16% |
25.00 |
192.61 |
38.52 |
231.13 |
Промяна на обстоятелства НСР-13617/25.08.2017 |
КЦ-1449/09.03.2010; протокол №16/04.07.2013. |
26.03.2010 |
02.10.2017 |
Неактивен |
902 |
| Human coagulation factor VIII |
9900223 |
Fanhdi, Powder and solvent for solution for injection, 1000, IU, Pack: 1 |
Instituto Grifols, S.A., Испания |
INSTITUTO GRIFOLS S.A.,Spain |
628.04 |
125.61 |
753.65 |
4% |
10.00 |
638.04 |
127.61 |
765.65 |
16% |
25.00 |
663.04 |
132.61 |
795.65 |
Промяна на обстоятелства НСР-13619/25.08.2017 |
КЦ-1449/09.03.2010; протокол №16/04.07.2013.; НСР-15711/25.05.2018 |
09.06.2018 |
02.07.2018 |
Активен |
904 |
| Human coagulation factor VIII |
9900223 |
Fanhdi, Powder and solvent for solution for injection, 1000, IU, Pack: 1 |
Instituto Grifols, S.A., Испания |
INSTITUTO GRIFOLS S.A.,Spain |
648.87 |
129.77 |
778.64 |
4% |
10.00 |
658.87 |
131.77 |
790.64 |
16% |
25.00 |
683.87 |
136.77 |
820.64 |
Промяна на обстоятелства НСР-13619/25.08.2017 |
КЦ-1449/09.03.2010; протокол №16/04.07.2013. |
26.03.2010 |
02.10.2017 |
Неактивен |
904 |
| Human coagulation factor VIII |
II-6210/18,11,2009 |
Fanhdi, Powder and solvent for solution for injection, 250, IU, Pack: 1 |
Instituto Grifols, S.A., Испания |
INSTITUTO GRIFOLS S.A.,Spain |
161.16 |
32.23 |
193.39 |
4% |
6.45 |
167.61 |
33.52 |
201.13 |
16% |
25.00 |
192.61 |
38.52 |
231.13 |
|
КЦ-1449/09.03.2010; протокол №16/04.07.2013. |
26.03.2010 |
26.03.2010 |
Неактивен |
902 |
| Human coagulation factor VIII |
II-6209/18,11,2009 |
Fanhdi, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Instituto Grifols, S.A., Испания |
INSTITUTO GRIFOLS S.A.,Spain |
324.43 |
64.89 |
389.32 |
4% |
10.00 |
334.43 |
66.89 |
401.32 |
16% |
25.00 |
359.43 |
71.89 |
431.32 |
|
КЦ-1449/09.03.2010; протокол №16/04.07.2013. |
26.03.2010 |
26.03.2010 |
Неактивен |
903 |
| Human coagulation factor VIII |
II-6211/18,11,2009 |
Fanhdi, Powder and solvent for solution for injection, 1000, IU, Pack: 1 |
Instituto Grifols, S.A., Испания |
INSTITUTO GRIFOLS S.A.,Spain |
648.87 |
129.77 |
778.64 |
4% |
10.00 |
658.87 |
131.77 |
790.64 |
16% |
25.00 |
683.87 |
136.77 |
820.64 |
|
КЦ-1449/09.03.2010; протокол №16/04.07.2013. |
26.03.2010 |
26.03.2010 |
Неактивен |
904 |
| Human coagulation factor VIII |
II-6211/18,11,2009 |
Fanhdi, Powder and solvent for solution for injection, 1000, IU, Pack: 1 |
Instituto Grifols, S.A., Испания |
INSTITUTO GRIFOLS S.A.,Spain |
648.87 |
129.77 |
778.64 |
4% |
10.00 |
658.87 |
131.77 |
790.64 |
16% |
25.00 |
683.87 |
136.77 |
820.64 |
|
КЦ-1449/09.03.2010; протокол №16/04.07.2013. |
26.03.2010 |
26.03.2010 |
Неактивен |
904 |
| Human coagulation factor VIII |
II-6209/18,11,2009 |
Fanhdi, Powder and solvent for solution for injection, 500, IU, Pack: 1 |
Instituto Grifols, S.A., Испания |
INSTITUTO GRIFOLS S.A.,Spain |
324.43 |
64.89 |
389.32 |
4% |
10.00 |
334.43 |
66.89 |
401.32 |
16% |
25.00 |
359.43 |
71.89 |
431.32 |
|
КЦ-1449/09.03.2010; протокол №16/04.07.2013. |
26.03.2010 |
26.03.2010 |
Неактивен |
903 |
| Human coagulation factor VIII |
II-6210/18,11,2009 |
Fanhdi, Powder and solvent for solution for injection, 250, IU, Pack: 1 |
Instituto Grifols, S.A., Испания |
INSTITUTO GRIFOLS S.A.,Spain |
161.16 |
32.23 |
193.39 |
4% |
6.45 |
167.61 |
33.52 |
201.13 |
16% |
25.00 |
192.61 |
38.52 |
231.13 |
|
КЦ-1449/09.03.2010; протокол №16/04.07.2013. |
26.03.2010 |
26.03.2010 |
Неактивен |
902 |
| Toremifene |
EU/1/96/004/001 |
Fareston, Tablet, 60, mg, Pack: 30 |
Orion Corporation, Финландия |
Orion Corporation Orion Pharma - Финландия |
29.53 |
5.91 |
35.44 |
6% |
1.77 |
31.30 |
6.26 |
37.56 |
18% |
5.32 |
36.62 |
7.32 |
43.94 |
НСР-13524/18.08.2017 и КП-103/25.10.2017 |
КП-56/25.07.2017; НСР-14541/27.11.2017 ( допуска предварително изпълнение ) |
27.11.2017 |
02.12.2017 |
Активен |
1217 |
| Toremifene |
EU/1/96/004/001 |
Fareston, Tablet, 60, mg, Pack: 30 |
Orion Corporation, Финландия |
Orion Corporation Orion Pharma - Финландия |
29.53 |
5.91 |
35.44 |
6% |
1.77 |
31.30 |
6.26 |
37.56 |
18% |
5.32 |
36.62 |
7.32 |
43.94 |
|
КП-56/25.07.2017 |
11.06.2012 |
02.08.2017 |
Неактивен |
1217 |
| Toremifene |
EU/1/96/004/001 |
Fareston, Tablet, 60, mg, Pack: 30 |
Orion Corporation, Финландия |
Orion Corporation Orion Pharma - Финландия |
29.53 |
5.91 |
35.44 |
6% |
1.77 |
31.30 |
6.26 |
37.56 |
18% |
5.32 |
36.62 |
7.32 |
43.94 |
|
КЦРР-613/18.05.2012; НСР-12233/03.04.2017 г. |
11.06.2012 |
02.05.2017 |
Заличен |
1217 |
| Toremifene |
EU/1/96/004/001 |
Fareston, Tablet, 60, mg, Pack: 30 |
Orion Corporation, Финландия |
Orion Corporation Orion Pharma - Финландия |
29.53 |
5.91 |
35.44 |
6% |
1.77 |
31.30 |
6.26 |
37.56 |
18% |
5.32 |
36.62 |
7.32 |
43.94 |
|
КЦРР-613/18.05.2012 |
11.06.2012 |
11.06.2012 |
Неактивен |
1217 |